Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6829

Inquiry Regarding CMS347v7 Satin Therapy for Prevention and Treatment of Cardiovascular Disease

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Whitney Damson
    • 202-955-1732
    • National Committee for Quality Assurance
    • Hide
      Thank you for your question on CMS347v7: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. The measure's fourth population is meant to capture patients with a high 10-year risk of ASCVD and who do not have ASCVD, diabetes, or high LDL.
      Show
      Thank you for your question on CMS347v7: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. The measure's fourth population is meant to capture patients with a high 10-year risk of ASCVD and who do not have ASCVD, diabetes, or high LDL.
    • CMS0347v7
    • This metric states both CVD and ASCVD seemingly interchangeably. Our EMR calculates separate CVD and ASCVD risk scores. Can your team clarify if this should be the ASCVD or CVD risk score for population 4?

          edave Mathematica EC eCQM Team
          wdamson Whitney Damson
          Votes:
          0 Vote for this issue
          Watchers:
          2 Start watching this issue

            Created:
            Updated:
            Resolved:
            Solution Posted On: